Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Cabaletta Bio, Inc. (CABA) had Income from Continuous Operations of $-43.52M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-43.52M |
|
-- |
|
-- |
|
$44.30M |
|
$-44.30M |
|
$0.78M |
|
$-43.52M |
|
$-43.52M |
|
$-43.52M |
|
|
Income from Continuous Operations |
$-43.52M |
$-43.52M |
|
$-43.52M |
|
$-44.30M |
|
$-44.25M |
|
112.03M |
|
112.03M |
|
$-0.39 |
|
$-0.39 |
|
| Balance Sheet Financials | |
$122.32M |
|
$1.58M |
|
$25.83M |
|
$148.15M |
|
$41.51M |
|
-- |
|
$3.33M |
|
$44.84M |
|
$103.31M |
|
$103.31M |
|
$103.31M |
|
111.33M |
|
| Cash Flow Statement Financials | |
$-42.56M |
|
$50.96M |
|
$25.27M |
|
$82.98M |
|
$116.64M |
|
$33.65M |
|
$5.26M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.95 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-42.56M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-42.12% |
|
-42.12% |
|
-29.37% |
|
-42.12% |
|
$0.93 |
|
$-0.38 |
|
$-0.38 |
|